ABSTRACT
Introduction Obstructive sleep apnoea (OSA) syndrome was first described in children in 1976 and has become an increasingly recognized problem. In children it is commonly associated with adenotonsillar hypertrophy and can be treated successfully by adenotonsillectomy. The dangers of perioperative upper airway obstruction and potential cardiovascular collapse demand expertise and vigilance from all members of the team involved in the management of these children.
